![]() |
市場調查報告書
商品編碼
2016133
造影注射器市場報告:按產品類型、注射器類型、應用、最終用戶和地區分類(2026-2034 年)Contrast Media Injectors Market Report by Product Type, Injectors Type, Application, End User, and Region 2026-2034 |
||||||
2025年,全球造影劑注射器市場規模達19億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到29億美元,2026年至2034年的複合年成長率(CAGR)為4.77%。該市場正經歷顯著成長,主要促進因素包括慢性病患病率上升、微創手術需求增加以及診斷成像程序數量不斷成長。此外,注射器系統的技術進步提高了造影劑輸送的效率和流暢性,從而創造了良好的市場前景。
先進技術的融合
將人工智慧 (AI) 和機器學習 (ML) 等先進技術整合到造影劑注射器中,透過提高注射過程的準確性和安全性,正在改變市場格局。 AI 演算法可以分析患者特定數據並最佳化造影劑劑量,從而最大限度地降低風險並改善診斷結果。機器學習有助於實現注射流程的自動化,減少人為錯誤,並確保各種操作流程的一致性。這些技術還支援即時監測和調整,從而更好地控制注射過程。隨著醫療機構擴大採用這些智慧注射器,在對更精準、更有效率的影像解決方案的需求驅動下,市場呈現出成長動能。例如,2023 年 11 月,德國醫療設備製造商 Ulrich Medical 與 Bracco Imaging 合作,在美國銷售 MRI造影劑輸液設備。 Ulrich Medical 已向美國食品藥物管理局(FDA) 提交了其無針 MRI輸液設備的510(k) 預先通知,最終促成了雙方正式簽署銷售協議。這項策略合作有望使 MRI 注射器與美國市場同步上市。
雙頭噴油嘴的廣泛應用
雙頭注射器可同時注射兩種類型的造影,因其能簡化診斷影像檢查的工作流程並提高病患處理能力,而日益普及。這項技術無需多次注射或手動處理不同的造影,即可完成更複雜的影像檢查。雙頭注射器透過縮短準備時間並提高造影劑注射的準確性,簡化了放射科的工作流程,最大限度地減少了患者的不適感,並最佳化了資源利用。因此,對於旨在提高營運效率的現代診斷成像科室而言,它們是極具價值的設備。例如,美敦力公司於2023年3月發布了Accutron CT-D Vision,這是一款用於造影斷層掃描(CT)的先進雙活塞CT顯影劑注射器。該輸液設備擁有方便用戶使用的介面、RIS/PACS介面、全面的注射數據可追溯性以及在放射科環境中的靈活移動性。此外,它還核准用於增強乳房X光攝影,透過減少靜脈造影顯影劑的流入量,提高影像質量,支援高效的工作流程,並增強病患安全性。
新興市場的擴張
新興市場的擴張是造影劑注射器市場的關鍵趨勢,其主要驅動力是醫療保健投資的增加和先進醫療技術的普及。亞太地區、拉丁美洲和中東的快速都市化和經濟成長正在推動醫療保健基礎設施的發展。各國政府和私營部門都在投資最先進的醫療設備,包括需要造影劑注射器的診斷影像技術。此外,這些地區慢性病發病率的上升也推動了對診斷影像檢查的需求。這種先進醫療保健服務可近性的提高為市場參與者推出了創新注射器,從而推動了市場成長。根據產業報告顯示,印度醫療保健產業2016年的價值為1,100億美元,預計到2025年將達到6,380億美元。該行業擁有750萬名員工,但由於勞動力短缺,對醫療保健專業人員的需求不斷成長。為了增加公共醫療保健支出,衛生署設定了 2025 年達到 GDP 2.5% 的目標。政府在 2024-25 財政年度的聯邦臨時預算中,已向衛生與家庭福利部撥款 9.0659 兆盧比。
The global contrast media injectors market size reached USD 1.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4.77% during 2026-2034. The market is experiencing significant growth mainly driven by the rising prevalence of chronic diseases, the growing demand for minimally invasive procedures and the rising number of diagnostic imaging procedures. Technological advancements in injector systems are also enhancing the efficiency and liquidity of contrast media delivery, thereby creating a positive market outlook.
Integration of Advanced Technologies
The integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML), in contrast media injectors is transforming the market by enhancing the precision and safety of injection processes. AI algorithms can analyze patient-specific data to optimize contrast media dosage, minimizing risks and improving diagnostic outcomes. Machine learning helps automate injection protocols, reducing human error and ensuring consistent performance across various procedures. These technologies also facilitate real-time monitoring and adjustments, providing better control over the injection process. As healthcare providers increasingly adopt these smart injectors, the market is poised for growth, driven by the demand for more accurate and efficient imaging solutions. For instance, in November 2023, German medical device manufacturer Ulrich Medical partnered with Bracco Imaging for the distribution of an MRI contrast media injector in the U.S. Ulrich Medical has submitted a premarket notification 510(k) to the U.S. Food and Drug Administration for the syringeless MRI injector, marking the finalization of the distribution agreement. This strategic cooperation is set to make the MRI injector available as soon as it is commercially released in the U.S.
Rising Adoption of Dual-Head Injectors
Dual-head injectors are becoming increasingly popular because they allow simultaneous injection of two different contrast agents, which improves workflow efficiency and patient throughput in diagnostic imaging procedures. This technology enables more complex imaging studies without the need for multiple injections or manual handling of different agents. By reducing preparation time and enhancing the accuracy of contrast delivery, dual-head injectors streamline radiology workflows, minimize patient discomfort, and optimize resource utilization, making them a valuable addition to modern imaging departments seeking to improve operational efficiency. For instance, in March 2023, Medtron AG introduced the Accutron CT-D Vision, a state-of-the-art CT double-piston contrast agent injector for computed tomography. The injector boasts a user-friendly interface, RIS/PACS interface, comprehensive traceability of injection data, and flexible mobility in radiology environments. Additionally, it has been approved for contrast-enhanced mammography, enhancing imaging quality, supporting efficient workflow, and improving patient safety by reducing contrast agent exposure in the veins.
Expansion in Emerging Markets
The expansion in emerging markets is a significant trend in the contrast media injectors market, driven by increased healthcare investments and the broader availability of advanced medical technologies. Countries in Asia-Pacific, Latin America, and the Middle East are witnessing rapid urbanization and economic growth, which fuels the development of healthcare infrastructure. Governments and private sectors are investing in modern medical equipment, including imaging technologies that require contrast media injectors. Additionally, the rising incidence of chronic diseases in these regions is facilitating the demand for diagnostic imaging. This growing accessibility to advanced healthcare services creates opportunities for market players to introduce innovative injectors, thereby boosting the market growth. According to industry reports, India's healthcare sector, valued at US$110 billion in 2016, is projected to reach US$638 billion by 2025. With 7.5 million employees, the sector faces a growing demand for healthcare professionals, driven by a shortage in the workforce. Aiming to increase public expenditure on healthcare, the Health Ministry targets 2.5% of GDP by FY25. The government allocated Rs. 90,659 crore for the Ministry of Health and Family Welfare in the Interim Union Budget 2024-25.
Consumables accounts for the majority of the market share
Consumables, such as syringes, tubing, and disposable injector parts, account for the majority of the contrast media injectors market share due to their recurring use in imaging procedures. These items are essential for each contrast injection, driving constant demand regardless of the type of injector system used. Hospitals and imaging centers prioritize consumables to ensure safety, hygiene, and compliance with regulations. The single-use nature of consumables minimizes cross-contamination risks, making them crucial in maintaining high standards of patient care. As diagnostic imaging procedures increase globally, the steady requirement for consumables continues to dominate the market, providing ongoing revenue for manufacturers. These factors are creating a positive contrast media injectors market outlook, highlighting the importance of consumables in ensuring safe and effective imaging procedures.
Single-head Injectors holds the largest share of the market
Single-head injectors hold the largest share of the contrast media injectors market due to their widespread use and cost-effectiveness. These injectors are designed for administering a single type of contrast agent, making them ideal for a range of standard imaging procedures like CT scans and X-rays. Their simplicity and ease of use make them a preferred choice in hospitals and imaging centers, particularly in regions with budget constraints or lower imaging volumes. Single-head injectors also have lower maintenance costs compared to dual-head injectors, further enhancing their appeal. According to the contrast media injectors market forecast, the demand for single-head injectors is expected to remain strong, driven by ongoing advancements in technology and the need for reliable, straightforward solutions in medical imaging.
Radiology represents the leading market segment
Radiology represents the leading segment in the contrast media injectors market due to its central role in diagnostic imaging. The growing prevalence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders has increased the need for accurate diagnostic tools, making radiology essential in healthcare. According to the report published by WHO, cardiovascular diseases claim 10,000 lives daily in European Region, with men more affected than women. The report reveals that over 42.5% of annual deaths are due to CVDs. Radiology departments utilize contrast media injectors extensively for procedures like CT, MRI, and X-ray, which require precise contrast agent administration to enhance image quality. According to the contrast media injectors market overview, the rising number of diagnostic imaging procedures, driven by the high incidence of chronic diseases, has significantly boosted the adoption of contrast media injectors in radiology departments worldwide. Advancements in radiology imaging techniques and the integration of advanced injector systems have further driven demand. Consequently, radiology remains the dominant segment, accounting for the highest usage and revenue generation in the market.
Hospitals represents the largest market share
Hospitals exhibit clear dominance in the contrast media injectors market due to their high patient volumes and extensive range of diagnostic imaging procedures. As primary healthcare providers, hospitals frequently perform CT scans, MRIs, and X-rays, which require the use of contrast media injectors to enhance image clarity and accuracy. The need for reliable, high-performance injectors in these settings drives continuous demand. Additionally, hospitals have greater budgets and resources to invest in advanced injector technologies, including automated systems that improve efficiency and patient safety. This dominance is further reinforced by the growing prevalence of chronic diseases, increasing the demand for diagnostic imaging services.
North America leads the market, accounting for the largest contrast media injectors market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for contrast media injectors.
North America leads the contrast media injectors market, accounting for the largest market share due to several factors, including advanced healthcare infrastructure and a high prevalence of chronic diseases requiring diagnostic imaging. The region's strong emphasis on early disease detection and preventive healthcare has led to the widespread adoption of imaging procedures like CT scans, MRIs, and X-rays, driving demand for contrast media injectors. Additionally, North America benefits from substantial investments in healthcare technology, encouraging the development and uptake of advanced injector systems. For instance, in July 2024, San Mateo County Health announced its partnership with Innovaccer to implement its healthcare AI platform, with a focus on enhancing patient care services. The platform aims to modernize technology infrastructure by aggregating patient data from multiple sources, enabling the creation of unified patient records. This integrated approach empowers providers to make more informed decisions that improve population health management and clinical outcomes, ultimately striving to promote longer and healthier lives for everyone in San Mateo County, California. Favorable reimbursement policies and the presence of key market players also contribute to North America's leading position in the market.